Compare Biocon with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs UNICHEM LAB - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON UNICHEM LAB BIOCON /
UNICHEM LAB
 
P/E (TTM) x 31.9 -48.1 - View Chart
P/BV x 3.8 1.2 321.7% View Chart
Dividend Yield % 0.3 1.2 22.1%  

Financials

 BIOCON    UNICHEM LAB
EQUITY SHARE DATA
    BIOCON
Mar-19
UNICHEM LAB
Mar-19
BIOCON /
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs707292 242.2%   
Low Rs554182 304.3%   
Sales per share (Unadj.) Rs91.9167.7 54.8%  
Earnings per share (Unadj.) Rs16.7-3.6 -460.2%  
Cash flow per share (Unadj.) Rs24.25.9 406.8%  
Dividends per share (Unadj.) Rs1.004.00 25.0%  
Dividend yield (eoy) %0.21.7 9.4%  
Book value per share (Unadj.) Rs101.6372.3 27.3%  
Shares outstanding (eoy) m600.0070.38 852.5%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x6.91.4 485.4%   
Avg P/E ratio x37.7-65.3 -57.8%  
P/CF ratio (eoy) x26.139.9 65.4%  
Price / Book Value ratio x6.20.6 974.5%  
Dividend payout %6.0-110.2 -5.4%   
Avg Mkt Cap Rs m378,33016,680 2,268.2%   
No. of employees `0006.12.6 235.6%   
Total wages/salary Rs m11,6532,393 486.9%   
Avg. sales/employee Rs Th8,994.34,535.2 198.3%   
Avg. wages/employee Rs Th1,900.7919.8 206.6%   
Avg. net profit/employee Rs Th1,635.3-98.2 -1,665.2%   
INCOME DATA
Net Sales Rs m55,14411,801 467.3%  
Other income Rs m1,444984 146.7%   
Total revenues Rs m56,58812,785 442.6%   
Gross profit Rs m15,883-835 -1,902.4%  
Depreciation Rs m4,478674 664.7%   
Interest Rs m70975 942.8%   
Profit before tax Rs m12,140-600 -2,024.3%   
Minority Interest Rs m90-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,123-343 -618.1%   
Profit after tax Rs m10,026-256 -3,923.6%  
Gross profit margin %28.8-7.1 -407.1%  
Effective tax rate %17.557.3 30.5%   
Net profit margin %18.2-2.2 -839.6%  
BALANCE SHEET DATA
Current assets Rs m48,22820,384 236.6%   
Current liabilities Rs m30,3765,029 604.0%   
Net working cap to sales %32.4130.1 24.9%  
Current ratio x1.64.1 39.2%  
Inventory Days Days68105 65.2%  
Debtors Days Days86135 63.4%  
Net fixed assets Rs m64,1309,023 710.7%   
Share capital Rs m3,000141 2,130.7%   
"Free" reserves Rs m57,98026,058 222.5%   
Net worth Rs m60,98026,199 232.8%   
Long term debt Rs m15,7660-   
Total assets Rs m121,92431,496 387.1%  
Interest coverage x18.1-7.0 -259.8%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.50.4 120.7%   
Return on assets %8.8-0.6 -1,537.8%  
Return on equity %16.4-1.0 -1,685.7%  
Return on capital %16.8-2.0 -838.0%  
Exports to sales %28.169.4 40.5%   
Imports to sales %18.90-   
Exports (fob) Rs m15,5068,188 189.4%   
Imports (cif) Rs m10,399NA-   
Fx inflow Rs m15,5068,188 189.4%   
Fx outflow Rs m10,399596 1,744.8%   
Net fx Rs m5,1077,592 67.3%   
CASH FLOW
From Operations Rs m11,546-3,278 -352.3%  
From Investments Rs m-7,138-2,860 249.6%  
From Financial Activity Rs m-2,417-24 9,987.6%  
Net Cashflow Rs m2,103-4,690 -44.8%  

Share Holding

Indian Promoters % 40.4 50.1 80.6%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 15.1 55.6%  
FIIs % 10.7 3.0 356.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 31.7 62.8%  
Shareholders   109,995 20,176 545.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   DR. DATSONS LABS  DISHMAN PHARMA  J.B.CHEMICALS  JUBILANT PHARMOVA   AJANTA PHARMA  

Compare BIOCON With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 300 Points Higher, Dow Futures Up by 86 Points(12:30 pm)

Share markets in India are presently trading on a strong note. The BSE Sensex is trading up by 379 points, up 0.8% at 49,585 levels.

Related Views on News

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


May 10, 2021 02:24 PM

TRACK BIOCON

BIOCON - ALEMBIC PHARMA COMPARISON

COMPARE BIOCON WITH

MARKET STATS